Shares of NeuroMetrix, Inc. (NASDAQ:NURO) shot up 9.1% during mid-day trading on Wednesday . The stock traded as high as $3.40 and last traded at $3.36. 579,157 shares traded hands during mid-day trading, an increase of 70% from the average session volume of 339,882 shares. The stock had previously closed at $3.08.
The firm’s 50 day moving average is $2.75 and its 200-day moving average is $2.05.
NeuroMetrix (NASDAQ:NURO) last released its quarterly earnings data on Thursday, October 22nd. The medical device company reported ($0.07) earnings per share (EPS) for the quarter. NeuroMetrix had a negative net margin of 38.80% and a negative return on equity of 71.00%. The business had revenue of $2.04 million during the quarter.
NeuroMetrix Company Profile (NASDAQ:NURO)
NeuroMetrix, Inc, a healthcare company, develops and markets products for the detection, diagnosis, and monitoring of peripheral nerve and spinal cord disorders. The company develops wearable neuro-stimulation therapeutic devices and point-of-care neuropathy diagnostic tests to address chronic health conditions, including chronic pain, sleep disorders, and diabetes.
Featured Story: Trading Ex-Dividend
Receive News & Ratings for NeuroMetrix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NeuroMetrix and related companies with MarketBeat.com's FREE daily email newsletter.